Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment
Histiocytic sarcoma (HS) is an extremely rare non‐Langerhans cell disorder with an
aggressive course and limited treatment options. Recent advances in molecular/genetic …
aggressive course and limited treatment options. Recent advances in molecular/genetic …
[引用][C] Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment
J Ansari, AR Naqash, R Munker, H El-Osta… - European Journal of …, 2016 - cir.nii.ac.jp
Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
[PDF][PDF] Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment
J Ansari, AR Naqash, R Munker, H El-Osta, S Master… - 2016 - researchgate.net
Histiocytic sarcoma (HS) is an extremely rare non-Langerhans cell disorder with an
aggressive course and limited treatment options. Recent advances in molecular/genetic …
aggressive course and limited treatment options. Recent advances in molecular/genetic …
Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment
J Ansari, AR Naqash, R Munker, H El‐Osta… - European Journal of …, 2016 - infona.pl
Histiocytic sarcoma (HS) is an extremely rare non‐Langerhans cell disorder with an
aggressive course and limited treatment options. Recent advances in molecular/genetic …
aggressive course and limited treatment options. Recent advances in molecular/genetic …
[PDF][PDF] Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment
J Ansari, AR Naqash, R Munker, H El-Osta… - European Journal of …, 2016 - academia.edu
Histiocytic sarcoma (HS) is an extremely rare non-Langerhans cell disorder with an
aggressive course and limited treatment options. Recent advances in molecular/genetic …
aggressive course and limited treatment options. Recent advances in molecular/genetic …
Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment
J Ansari, AR Naqash, R Munker… - European journal …, 2016 - pubmed.ncbi.nlm.nih.gov
Histiocytic sarcoma (HS) is an extremely rare non-Langerhans cell disorder with an
aggressive course and limited treatment options. Recent advances in molecular/genetic …
aggressive course and limited treatment options. Recent advances in molecular/genetic …
Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment.
J Ansari, AR Naqash, R Munker, H El-Osta… - European Journal of …, 2016 - europepmc.org
Histiocytic sarcoma (HS) is an extremely rare non-Langerhans cell disorder with an
aggressive course and limited treatment options. Recent advances in molecular/genetic …
aggressive course and limited treatment options. Recent advances in molecular/genetic …
Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment.
J Ansari, AR Naqash, R Munker… - European Journal …, 2016 - search.ebscohost.com
Histiocytic sarcoma (HS) is an extremely rare non-Langerhans cell disorder with an
aggressive course and limited treatment options. Recent advances in molecular/genetic …
aggressive course and limited treatment options. Recent advances in molecular/genetic …